811. New Insights in Management of Complicated UTIs and Prevention of Recurrent UTIs
Session: Meet-the-Professor Session: Urinary Tract Infections - New Insights and Strategies
Saturday, October 22, 2011: 7:00 AM
Room: 157ABC
To get insight into new strategies concerning the prevention (with non-antibiotic prophylaxis), diagnosis (the role of bloodcultures and radiologic imaging) and treatment of urinary tract infections.

Suzanne Geerlings, MD, PhD, Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, and Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, Netherlands

Suzanne.E. Geerlings is an Infectious Disease specialist and staff member at the Department of Infectious Diseases, Tropical Medicine and AIDS at the Academic Medical Center (AMC) in Amsterdam. The subject of her thesis was “Asymptomatic bacteriuria in women with diabetes mellitus: pathogenesis, risk factors and consequences.” She continued this line of research as a co-promotor and received two awards for it. She was author of many guidelines concerning urinary tract infections: the main author of the Dutch Working Party on Antibiotic Policy (SWAB)- guideline ‘Antimicrobial treatment of complicated urinary tract infections’ and member of the working groups for the guidelines Urinary tract infections of the Dutch College of General Practitioners (NHG-standaard), the Netherlands Society for Urology (NVU) and the Infectious Diseases Society of America (IDSA). At this moment, she is projectleader of the following studies, all about urinary tract infections or quality of antibiotic treatment, namely: Non-antibiotic versus antibiotic prophylaxis for recurrent urinary tract infections (NAPRUTI)-study, (Cost)-Effectiveness of two different strategies to improve the quality of antibiotic use in patients with urinary tract infections (QUANTI-study), Development of generic quality indicators for the optimalisation of antibiotic use in the hospital (will start December 2010) (all granted by the Netherlands Organisation for Health Research and Development) and member of the projectgroup in many other studies all about urinary tract infections, HIV or quality of care (not only concerning antibiotic treatment).

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.